Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?

Gut. 2024 Dec 20:gutjnl-2024-334069. doi: 10.1136/gutjnl-2024-334069. Online ahead of print.

Yenkai Lim^#^{1

2}, Seungha Kang^#^{1

2}, Ayesha Shah^#^{2

3

4}, Gerald Holtmann^#^{2

3

4}, Mark Morrison^#^{5

2

3}

¹ Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia.
² NHMRC Centre of Research Excellence for Digestive Health, The University of Queensland, Saint Lucia, Queensland, Australia.
³ Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
⁴ Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
⁵ Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Queensland, Australia m.morrison1@uq.edu.au.

^# Contributed equally.

No abstract available

Keywords: inflammatory bowel disease; intestinal microbiology; primary sclerosing cholangitis.

Publication types